(HealthDay)—The drug artesunate—the World Health Organization-recommended first-line treatment for severe malaria—will become the first-line treatment for severe malaria in the United States, the U.S. Centers for Disease Control and Prevention says in a new guidance to health care providers.
* This article was originally published here
